Boston Scientific Corporation (BSX)
Boston Scientific makes minimally invasive medical devices for cardiology, urology, and other specialties.
Health Care stock comparison
BSX vs COR: which business are you actually underwriting?
Compare Boston Scientific Corporation with Cencora, Inc. using their business models, SEC classifications, fiscal calendars, current primary filings, and the research questions that matter. This is a thesis framework—not a price target or automatic winner.
- Sector
- Health
- Industry
- Different SIC
- Shared themes
- 1
- Updated
- 2026-02-17
BSX vs COR: quick comparison
| Company fact | BSX | COR |
|---|---|---|
| Company | Boston Scientific Corporation | Cencora, Inc. |
| Exchange | NYSE | NYSE |
| Headquarters | Not recorded | Not recorded |
| Founded | Not recorded | Not recorded |
| SEC industry | Surgical & Medical Instruments & Apparatus | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Fiscal year-end | December 31 | September 30 |
| Latest annual filing | 10-K · 2026-02-17 | 10-K · 2025-11-25 |
How the businesses differ
Cencora, Inc. (COR)
Cencora is a pharmaceutical wholesaler distributing drugs and providing specialty and logistics services.
The useful starting point is not which ticker has performed better. It is whether the two companies convert the same economic forces into revenue and cash flow in the same way. BSX is classified by the SEC as Surgical & Medical Instruments & Apparatus, while COR is classified as Wholesale-Drugs, Proprietaries & Druggists' Sundries. The different industry codes are a warning against treating sector membership as proof of identical economics.
Which thesis does each company fit?
Use the distinction below to decide which filing deserves deeper work. It is a research routing rule, not a recommendation or prediction.
Study BSX when…
- Drug approvals and clinical-trial readouts
- Medicare and drug-pricing policy
- Demographics and an aging population
- GLP-1 and obesity-drug demand
Study COR when…
- Drug approvals and clinical-trial readouts
- Medicare and drug-pricing policy
- Demographics and an aging population
- GLP-1 and obesity-drug demand
Shared research themes
US markets
SEC filing comparison and disclosure evidence
Start with primary filings because fiscal calendars and accounting presentation can make superficially similar quarters incomparable.BSX's fiscal year ends December 31, while COR's ends September 30. Normalize the reporting periods before comparing growth, margins, capital intensity, or guidance.
The current verified House Clerk snapshot contains 0matched transaction rows for BSXand 0 for COR. These delayed, range-based disclosures can identify a filing to inspect; they do not establish motive, conviction, or a real-time trading signal.
BSX primary filings
COR primary filings
What this comparison cannot tell you
This page does not contain licensed live prices, a valuation model, earnings estimates, portfolio constraints, or a forecast of future returns. SEC classifications can be broad, company descriptions can lag strategic change, and the latest annual filing may predate a material acquisition or divestiture. Read subsequent quarterly and current reports before making a decision.
A stronger business is not automatically the better stock. Starting valuation, expectations, capital structure, cyclicality, dilution, and the probability of each thesis determine the investment outcome. Use this comparison to frame the work, then verify the numbers in the linked filings and current company disclosures.
More comparisons involving BSX or COR
BSX vs COR FAQs
Are BSX and COR direct competitors?
Boston Scientific Corporation and Cencora, Inc. sit in the same Health Care sector but have different SEC industry classifications. The comparison is most useful for portfolio role and sector exposure, not as a claim that every product competes directly.
Which is better, BSX or COR?
There is no context-free winner. Compare the operating exposures, filing evidence, valuation, balance sheet, and risks against the specific thesis you are testing. This page deliberately does not turn a static profile into a buy or sell recommendation.
Does this BSX vs COR comparison include live prices?
No. Yield Theory does not republish unlicensed real-time market data. Use a regulated broker or licensed quote provider for current prices, then use the primary filings here to test the business thesis.
Where does the company information come from?
Company classifications, fiscal year-ends, and filing links come from the SEC EDGAR submissions API snapshot refreshed 2026-08-10. Business summaries and research themes are maintained by Yield Theory.
Data snapshot: SEC EDGAR submissions API, refreshed 2026-08-10. Independent educational research; not investment advice.
Go beyond BSX vs COR.
Yield Theory connects filings, capital flows, catalysts, and risks into an investable research process.
$15/mo or $150/yr · cancel future renewals anytime · sources included